Cargando…

Clinical findings, synovial fluid cytology and growth factor concentrations after intra-articular use of a platelet-rich product in horses with osteoarthritis

Osteoarthritis is a common cause of lameness in horses, resulting in poor performance. Intra-articular platelet-rich plasma can deliver a collection of bioactive molecules, such as autologous growth factors and proteins involved in the quality of tissue repair. Horses (n=5) with osteoarthritis affec...

Descripción completa

Detalles Bibliográficos
Autores principales: Smit, Yolandi, Marais, Hendrik J., Thompson, Peter N., Mahne, Arnold T., Goddard, Amelia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AOSIS 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6556911/
https://www.ncbi.nlm.nih.gov/pubmed/31170778
http://dx.doi.org/10.4102/jsava.v90i0.1721
_version_ 1783425384260304896
author Smit, Yolandi
Marais, Hendrik J.
Thompson, Peter N.
Mahne, Arnold T.
Goddard, Amelia
author_facet Smit, Yolandi
Marais, Hendrik J.
Thompson, Peter N.
Mahne, Arnold T.
Goddard, Amelia
author_sort Smit, Yolandi
collection PubMed
description Osteoarthritis is a common cause of lameness in horses, resulting in poor performance. Intra-articular platelet-rich plasma can deliver a collection of bioactive molecules, such as autologous growth factors and proteins involved in the quality of tissue repair. Horses (n=5) with osteoarthritis affecting antebrachiocarpal, middle carpal or metacarpophalangeal joints, and horses (n=5) without osteoarthritis of the corresponding joints (radiographically free of osteoarthritis), were used for the production of platelet-rich plasma which was subsequently injected into selected joints. Clinical and synovial fluid changes after intra-articular injection of platelet-rich plasma as well as synovial platelet-derived growth factor-BB and transforming growth factor-beta 1 concentration changes were evaluated in these joints and compared between normal joints and joints with osteoarthritis. A gravity filtration system produced a moderately concentrated platelet-rich plasma, representing a 4.7-fold increase in baseline platelet concentration. The synovial effusion score was significantly different between the control joints and joints with osteoarthritis on Day 0 with a higher score in the group with osteoarthritis. Within the control group, the synovial effusion score was significantly higher on Days 1 and 2 compared to Day 0. For both groups, the synovial fluid nucleated cell count, predominantly intact neutrophils, was significantly increased on Days 1 and 2, with no significant difference between groups. The mean synovial platelet-derived growth factor-BB and transforming growth factor-beta 1 concentrations were increased for both groups but significantly lowered in the group with osteoarthritis on Day 1 compared to normal joints. Concentrations for platelet-derived growth factor-BB remained unchanged on Day 5, compared to Day 1, with no significant difference between groups. In conclusion, intra-articular treatment with platelet-rich plasma resulted in increased synovial growth factor concentrations in joints but with lower concentrations in joints with osteoarthritis. A transient inflammatory reaction was seen both clinically as an increase in synovial effusion and cytologically in both normal joints and joints with osteoarthritis. KEYWORDS: horse; osteoarthritis; platelet-rich plasma; intra-articular.
format Online
Article
Text
id pubmed-6556911
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher AOSIS
record_format MEDLINE/PubMed
spelling pubmed-65569112019-06-14 Clinical findings, synovial fluid cytology and growth factor concentrations after intra-articular use of a platelet-rich product in horses with osteoarthritis Smit, Yolandi Marais, Hendrik J. Thompson, Peter N. Mahne, Arnold T. Goddard, Amelia J S Afr Vet Assoc Original Research Osteoarthritis is a common cause of lameness in horses, resulting in poor performance. Intra-articular platelet-rich plasma can deliver a collection of bioactive molecules, such as autologous growth factors and proteins involved in the quality of tissue repair. Horses (n=5) with osteoarthritis affecting antebrachiocarpal, middle carpal or metacarpophalangeal joints, and horses (n=5) without osteoarthritis of the corresponding joints (radiographically free of osteoarthritis), were used for the production of platelet-rich plasma which was subsequently injected into selected joints. Clinical and synovial fluid changes after intra-articular injection of platelet-rich plasma as well as synovial platelet-derived growth factor-BB and transforming growth factor-beta 1 concentration changes were evaluated in these joints and compared between normal joints and joints with osteoarthritis. A gravity filtration system produced a moderately concentrated platelet-rich plasma, representing a 4.7-fold increase in baseline platelet concentration. The synovial effusion score was significantly different between the control joints and joints with osteoarthritis on Day 0 with a higher score in the group with osteoarthritis. Within the control group, the synovial effusion score was significantly higher on Days 1 and 2 compared to Day 0. For both groups, the synovial fluid nucleated cell count, predominantly intact neutrophils, was significantly increased on Days 1 and 2, with no significant difference between groups. The mean synovial platelet-derived growth factor-BB and transforming growth factor-beta 1 concentrations were increased for both groups but significantly lowered in the group with osteoarthritis on Day 1 compared to normal joints. Concentrations for platelet-derived growth factor-BB remained unchanged on Day 5, compared to Day 1, with no significant difference between groups. In conclusion, intra-articular treatment with platelet-rich plasma resulted in increased synovial growth factor concentrations in joints but with lower concentrations in joints with osteoarthritis. A transient inflammatory reaction was seen both clinically as an increase in synovial effusion and cytologically in both normal joints and joints with osteoarthritis. KEYWORDS: horse; osteoarthritis; platelet-rich plasma; intra-articular. AOSIS 2019-05-23 /pmc/articles/PMC6556911/ /pubmed/31170778 http://dx.doi.org/10.4102/jsava.v90i0.1721 Text en © 2019. The Authors https://creativecommons.org/licenses/by/4.0/ Licensee: AOSIS. This work is licensed under the Creative Commons Attribution License.
spellingShingle Original Research
Smit, Yolandi
Marais, Hendrik J.
Thompson, Peter N.
Mahne, Arnold T.
Goddard, Amelia
Clinical findings, synovial fluid cytology and growth factor concentrations after intra-articular use of a platelet-rich product in horses with osteoarthritis
title Clinical findings, synovial fluid cytology and growth factor concentrations after intra-articular use of a platelet-rich product in horses with osteoarthritis
title_full Clinical findings, synovial fluid cytology and growth factor concentrations after intra-articular use of a platelet-rich product in horses with osteoarthritis
title_fullStr Clinical findings, synovial fluid cytology and growth factor concentrations after intra-articular use of a platelet-rich product in horses with osteoarthritis
title_full_unstemmed Clinical findings, synovial fluid cytology and growth factor concentrations after intra-articular use of a platelet-rich product in horses with osteoarthritis
title_short Clinical findings, synovial fluid cytology and growth factor concentrations after intra-articular use of a platelet-rich product in horses with osteoarthritis
title_sort clinical findings, synovial fluid cytology and growth factor concentrations after intra-articular use of a platelet-rich product in horses with osteoarthritis
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6556911/
https://www.ncbi.nlm.nih.gov/pubmed/31170778
http://dx.doi.org/10.4102/jsava.v90i0.1721
work_keys_str_mv AT smityolandi clinicalfindingssynovialfluidcytologyandgrowthfactorconcentrationsafterintraarticularuseofaplateletrichproductinhorseswithosteoarthritis
AT maraishendrikj clinicalfindingssynovialfluidcytologyandgrowthfactorconcentrationsafterintraarticularuseofaplateletrichproductinhorseswithosteoarthritis
AT thompsonpetern clinicalfindingssynovialfluidcytologyandgrowthfactorconcentrationsafterintraarticularuseofaplateletrichproductinhorseswithosteoarthritis
AT mahnearnoldt clinicalfindingssynovialfluidcytologyandgrowthfactorconcentrationsafterintraarticularuseofaplateletrichproductinhorseswithosteoarthritis
AT goddardamelia clinicalfindingssynovialfluidcytologyandgrowthfactorconcentrationsafterintraarticularuseofaplateletrichproductinhorseswithosteoarthritis